🧪RNA Therapeutics (non-mRNA)
RNA-based medicines including siRNA, antisense oligonucleotides, and RNA interference therapies for genetic diseases.
Market Cap$926.4B
1D-1.09%
Companies237
Public Cos17
SECTOR MARKET CAP
$926.4B+15790.4%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $809.7B | LLY |
| 2 |  | United States | $41.4B | ALNY |
| 3 |  | United States | $26.6B | BIIB |
| 4 |  | United States | $11.7B | IONS |
| 5 |  | United States | $7.9B | ARWR |
| 6 |  | Switzerland | $5.9B | BANB.SW |
| 7 |  | United States | $5.4B | PTCT |
| 8 |  | United States | $1.8B | SRPT |
| 9 |  | United States | $830.0M | SANA |
| 10 |  | United States | $547.7M | SLDB |
| 11 |  | United States | $433.0M | TRDA |
| 12 |  | United States | $376.1M | BNTC |
| 13 |  | France | $369.3M | ALSEN.PA |
| 14 |  | United States | $324.8M | PEPG |
| 15 |  | United States | $259.4M | CAMP |
| 16 |  | United States | $106.6M | KRRO |
| 17 |  | United States | $7.0M | ALZN |